Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.31 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25200083 | 1.00 | USP2 (0.33) | USP2CYP3A4KCNJ5KCNJ3CYP19A1 | |
| SCHEMBL29275511 | 0.87 | — | — | |
| SCHEMBL31348323 | 0.85 | CYP3A4 (0.36) | USP2CYP3A4CYP19A1PTGS1HSD11B1 | |
| SCHEMBL25232601 | 0.85 | CYP3A4 (0.36) | USP2CYP3A4CYP19A1PTGS1HSD11B1 | |
| SCHEMBL25215465 | 0.84 | USP2 (0.33) | USP2CYP3A4CYP19A1PTGS1 | |
| SCHEMBL30415739 | 0.84 | USP2 (0.33) | USP2CYP3A4CYP19A1PTGS1 | |
| SCHEMBL25220587 | 0.82 | GAA (0.36) | USP2CYP3A4CYP19A1PTGS1 | |
| SCHEMBL29275527 | 0.81 | — | — | |
| SCHEMBL11455423 | 0.80 | TRPM8 (0.32) | — | |
| SCHEMBL11455425 | 0.80 | TRPM8 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4405323-B1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH & CIE (CH) | 2026-01-14 | — | — | EP | disclosed |
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2025-01-30 | — | — | US | disclosed |
| EP-4405323-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | Firmenich SA (CH) | 2024-07-31 | — | — | EP | disclosed |
| WO-2023094502-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2023-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | DHPS, FDFT1, CYP17A1 | USP2 2881/4885CYP3A4 74/4885KCNJ5 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.